Cargando…

Thrombosis after liver transplantation for hepatocellular carcinoma

The influence of thrombosis on the prognosis of patients with hepatocellular carcinoma (HCC) after liver transplantation (LT) and the role of the commonest inherited thrombophilia abnormalities factor V Leiden and prothrombin G20210A in the development of thrombosis are unknown. We investigated a co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martinelli, Ida, Ponziani, Francesca R., Maino, Alberto, Bhoori, Sherrie, Abbattista, Maria, Maggi, Umberto, De Feo, Tullia M., Bucciarelli, Paolo, Artoni, Andrea, Longhi, Elena, Serafini, Marta, Rossi, Giorgio, Mazzaferro, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658078/ https://www.ncbi.nlm.nih.gov/pubmed/29073275 http://dx.doi.org/10.1371/journal.pone.0186699

Ejemplares similares

Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio as Risk Factors for Venous Thrombosis
por: Artoni, Andrea, et al.
Publicado: (2017)

COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy
por: Bhoori, Sherrie, et al.
Publicado: (2020)

Liver Transplantation for Hepatocellular Carcinoma
por: Mazzaferro, Vincenzo, et al.
Publicado: (2008)

Trans-arterial radioembolization in intermediate-advanced hepatocellular carcinoma: systematic review and meta-analyses
por: Rognoni, Carla, et al.
Publicado: (2016)

Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis
por: Rognoni, Carla, et al.
Publicado: (2018)

Failure of Intravenous Silibinin Monotherapy to Prevent Hepatitis C Genotype 2A Liver Graft Reinfection
por: Aghemo, Alessio, et al.
Publicado: (2012)

Y(90)-radioembolisation in hepatocellular carcinoma induces immune responses calling for early treatment with multiple checkpoint blockers
por: Rivoltini, Licia, et al.
Publicado: (2023)

Comparison of adverse drug reactions among four COVID‐19 vaccines in Europe using the EudraVigilance database: Thrombosis at unusual sites
por: Abbattista, Maria, et al.
Publicado: (2021)

Liver Retransplantation in Adults: The Largest Multicenter Italian Study
por: Maggi, Umberto, et al.
Publicado: (2012)

Liver Transplantation for Hepatic Metastases from Colorectal Cancer: Current Knowledge and Open Issues
por: Maspero, Marianna, et al.
Publicado: (2023)

Thrombotic Complications in Patients with Immune-Mediated Hemolysis
por: Capecchi, Marco, et al.
Publicado: (2021)

European Society of Organ Transplantation (ESOT) Consensus Report on Downstaging, Bridging and Immunotherapy in Liver Transplantation for Hepatocellular Carcinoma
por: Claasen, Marco Petrus Adrianus Wilhelmus, et al.
Publicado: (2023)

Role of ADAMTS13, VWF and F8 genes in deep vein thrombosis
por: Pagliari, Maria Teresa, et al.
Publicado: (2021)

Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers
por: Cerrito, Lucia, et al.
Publicado: (2019)

Role of gadoxetic acid-enhanced liver magnetic resonance imaging in the evaluation of hepatocellular carcinoma after locoregional treatment
por: Gatti, Marco, et al.
Publicado: (2022)

Radioembolization of Hepatocellular Carcinoma with (90)Y Glass Microspheres: No Advantage of Voxel Dosimetry with Respect to Mean Dose in Dose–Response Analysis with Two Radiological Methods
por: Romanò, Chiara, et al.
Publicado: (2022)

Anticoagulant Therapy in Patients with Antiphospholipid Syndrome
por: Capecchi, Marco, et al.
Publicado: (2022)

Liver magnetic resonance imaging for evaluation of response to treatment after stereotactic body radiation therapy of hepatocellular carcinoma
por: Serafini, Alessandro, et al.
Publicado: (2022)

Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy.
por: Pinato, David J., et al.
Publicado: (2021)

Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management
por: Spada, Francesca, et al.
Publicado: (2021)

Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case–Control Studies
por: Nemeth, Banne, et al.
Publicado: (2015)

Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma
por: Pinato, David J., et al.
Publicado: (2023)

Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma
por: Sposito, Carlo, et al.
Publicado: (2022)

Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma
por: Zanetto, Alberto, et al.
Publicado: (2018)

Molecular Mechanisms Underlying Vascular Liver Diseases: Focus on Thrombosis
por: Giuli, Lucia, et al.
Publicado: (2023)

Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria
por: Beumer, Berend R., et al.
Publicado: (2022)

Liver transplantation for hepatocellular carcinoma with portal vein tumor thrombosis
por: Kim, Sang Jin, et al.
Publicado: (2021)

Visceral Artery Aneurysms in Liver Transplant Candidates and in Patients after Liver Transplantation
por: Maggi, Umberto, et al.
Publicado: (2011)

Microvascular Thrombosis and Liver Fibrosis Progression: Mechanisms and Clinical Applications
por: Airola, Carlo, et al.
Publicado: (2023)

Solid Organ Transplantation in the Coronavirus Disease 2019 Era: “The Great Bet” in the North Italy Transplant Program Area
por: Passamonti, Serena Maria, et al.
Publicado: (2020)

Increasing dosages of low-molecular-weight heparin in hospitalized patients with Covid-19
por: Martinelli, Ida, et al.
Publicado: (2021)

Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial
por: Geissler, Edward K., et al.
Publicado: (2016)

Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinoma
por: Ponziani, Francesca Romana, et al.
Publicado: (2019)

Survival benefit from liver transplantation for patients with and without hepatocellular carcinoma
por: Goudsmit, Ben F.J., et al.
Publicado: (2023)

Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach
por: Mazzaferro, Vincenzo
Publicado: (2016)

Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients
por: Faccia, Mariella, et al.
Publicado: (2022)

Targeted sequencing to identify novel genetic risk factors for deep vein thrombosis: a study of 734 genes
por: DE HAAN, H. G., et al.
Publicado: (2018)

Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma
por: Mazzaferro, Vincenzo, et al.
Publicado: (2018)

Evidence of Distinct Tumour-Propagating Cell Populations with Different Properties in Primary Human Hepatocellular Carcinoma
por: Colombo, Federico, et al.
Publicado: (2011)

Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients
por: Cucchetti, Alessandro, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f3q8pg1ok5na16r38edvev8rpn